Emergency approval for DRDO's anti-Covid drug 2-DG; trials claim reduced oxygen dependence, faster recovery



from Healthcare/Biotech-Industry-Economic Times https://ift.tt/33t91IZ
via IFTTT

0 comments:

Post a Comment